FDA recalls Atorvastatin Calcium tablets nationwide for potential efficacy issues

The FDA has initiated a nationwide recall of over 140,000 bottles of Atorvastatin Calcium tablets, a cholesterol-lowering medication. The recall is due to the medication failing dissolution specifications, meaning it may not be as effective as intended. Consumers should check their medication and consult a healthcare provider. This Class II recall indicates a low risk of serious health consequences, though temporary or reversible adverse effects are possible.